Artio closes $28M as it scales to save lives; latest funding brings Prairie Village startup’s investments to $74M
June 16, 2022 | Startland News Staff
Another hefty funding round for Artio Medical is expected to launch the startup’s commercial sales team in the U.S. and continue development of its best-in-class product pipeline, said founder Nicholas Franano.
Artio, a medical device company developing innovative products for the peripheral vascular, neurovascular, and cardiology markets, on Thursday announced the closing of $28 million in oversubscribed Series A2 and Series A3 financing, bringing the total amount raised to date to $74 million.
Funds will be used to support U.S. commercialization efforts for the recently cleared Solus Gold Embolization Device and to accelerate the development of Artio’s broad portfolio of products, including expanding the company’s engineering and manufacturing capabilities, Franano said in a press release.
Click here to read more about Artio’s $12 million funding infusion in 2021.
“We would like to thank our existing investors for their continued strong support and also welcome a new group of investors to Artio,” said Joseph McConnell, vice president of finance and business operations at Artio.
“We have the opportunity to do something really special here, to bring a new generation of medical devices to market with the potential to save lives, reduce disability, and improve the quality of life for millions of people,” McConnell continued. “This new capital will help Artio expand our team and scale our operations to deliver on that mission.”
Artio is currently developing ten products for the peripheral vascular market, including the Solus Gold and Solus Flex Embolization Devices for peripheral vessel occlusion and the Amplifi Vein Dilation System which is designed to prepare hemodialysis patients for successful arteriovenous fistula vascular access site creation.
Artio is also currently developing four products for the neurovascular market, including the Endura Embolization System comprising a detachable balloon and coils for the treatment of saccular brain aneurysms.
Click here to learn more about Artio’s portfolio of products.
2022 Startups to Watch
stats here
Related Posts on Startland News
MADI Apparel founder: ‘It’s not just underwear, it’s dignity’
Hayley Besheer relocated her apparel company’s headquarters from Florida to Kansas City after discovering a vibrant entrepreneurial ecosystem and curious customer base, the founder of MADI Apparel said. “Here [in KC] it feels more like [customers can] come into our space and can learn about the mission and [in Florida] everything was sold on online,”…
Year-end roundup: Checking in with Startland’s 2018 Startups to Watch
It was a year of refinement, said Chris Goode, as well as a time to rejoice amid highs and lows at Ruby Jean’s Juicery. Startland checked in with the founder, along with his fellow 2018 Startups to Watch companies, to see if the past 12 months unfolded as predicted. While working to expand Ruby Jean’s…
American Voter App gives power, political sway back to the people, founders say
Gamifying the political process could score a more engaged voting public, said Dan Prince, co-founder of the American Voter App, explaining the still-developing technology would be the first to put the power of the ballot box conveniently into users’ smartphones, he said. “We all realize our obligation to be informed and educated and vote on…
Edison Jumpstart grants offer early stage startups an office space entry point
A new grants program will give entrepreneurs the opportunity to “try it before you buy it” — removing a barrier to entry for young startups looking for high-end office space, said Matt Druten, announcing the Edison Jumpstart Program. “We’ve always said [Edison Spaces’ flexible office setup] was built by entrepreneurs for entrepreneurs,” said Druten, CEO…